1. Home
  2. PRME vs IBCP Comparison

PRME vs IBCP Comparison

Compare PRME & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.00

Market Cap

526.0M

Sector

Health Care

ML Signal

N/A

Logo Independent Bank Corporation

IBCP

Independent Bank Corporation

N/A

Current Price

$35.44

Market Cap

829.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRME
IBCP
Founded
2019
1864
Country
United States
United States
Employees
N/A
270
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
526.0M
829.6M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
PRME
IBCP
Price
$3.00
$35.44
Analyst Decision
Buy
Hold
Analyst Count
14
5
Target Price
$7.11
★ $40.40
AVG Volume (30 Days)
★ 2.7M
125.4K
Earning Date
11-06-2026
10-27-2026
Dividend Yield
N/A
★ 3.18%
EPS Growth
★ 18.18
3.48
EPS
N/A
★ 1.72
Revenue
$4,632,000.00
★ $32,075,000.00
Revenue This Year
$90.67
$23.05
Revenue Next Year
$19.46
$10.09
P/E Ratio
★ N/A
$20.58
Revenue Growth
★ 55.28
0.30
52 Week Low
$2.67
$29.83
52 Week High
$6.94
$39.24

Technical Indicators

Market Signals
Indicator
PRME
IBCP
Relative Strength Index (RSI) 44.33 33.99
Support Level $2.77 $33.96
Resistance Level $3.70 $35.40
Average True Range (ATR) 0.23 0.56
MACD -0.02 -0.10
Stochastic Oscillator 31.45 11.55

Price Performance

Historical Comparison
PRME
IBCP

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About IBCP Independent Bank Corporation

Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.

Share on Social Networks: